Reducing inflammation to delay the progression of Parkinson’s disease
Wouldn’t we all love to stop our Parkinson’s progressing? Have you ever heard of neuroinflammation? Did you know that Parkinson’s disease is associated with neuroinflammation in the brain and gut?
We are so fortunate to have a leading researcher into this complex area of Parkinson’s right here in Aotearoa. Louise Parr-Brownlie will break down the science to help us to understand whether inflammation increases the risk, or is a consequence, of Parkinson’s disease and what may be causing the inflammation in the first place. The presentation will also discuss how inflammation can be reduced, and explore if future anti-inflammatory mechanisms can be harnessed to slow the progression of Parkinson’s disease symptoms.
Louise Parr-Brownlie (Ngāti Maniapoto me Te Arawa) completed her PhD at the University of Otago before being a postdoctoral fellow at the National Institutes of Health in the United States. Louise joined the Department of Anatomy at the University of Otago in 2010. Louise is a neurophysiologist investigating how neuronal activity in the basal ganglia, motor thalamus and motor cortex controls movement, and characterises changes associated with Parkinson’s disease. She has investigated the utility of optogenetic stimulation applied to the motor thalamus to recover movements in parkinsonian models. Current research includes investigating if treatment strategies that reduce neuroinflammation can slow the progression of Parkinson’s disease.